Resumen de acción GTII
Green Thumb Industries Inc. fabrica, distribuye, comercializa y vende productos de cannabis para uso médico y para adultos en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
GTII ha superado nuestros controles de riesgos.
Competidores de Green Thumb Industries Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$16.66 |
| 52 Week High | CA$21.50 |
| 52 Week Low | CA$8.62 |
| Beta | 1.63 |
| 1 Month Change | -12.77% |
| 3 Month Change | -8.56% |
| 1 Year Change | 51.45% |
| 3 Year Change | -54.31% |
| 5 Year Change | -4.80% |
| Change since IPO | 86.15% |
Noticias y actualizaciones recientes
Green Thumb Industries Inc. (CSE:GTII) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 12
Green Thumb Industries Inc.'s (CSE:GTII) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 28Recent updates
Green Thumb Industries Inc. (CSE:GTII) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 12Green Thumb Industries Inc.'s (CSE:GTII) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 28Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Feb 29Subdued Growth No Barrier To Green Thumb Industries Inc.'s (CSE:GTII) Price
Dec 19Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 31Green Thumb Industries (CSE:GTII) Takes On Some Risk With Its Use Of Debt
May 28These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Feb 27With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Feb 05Green Thumb Industries (CSE:GTII) Seems To Use Debt Quite Sensibly
Nov 27If EPS Growth Is Important To You, Green Thumb Industries (CSE:GTII) Presents An Opportunity
Oct 17Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 09With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Jul 19Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Apr 23Earnings Tell The Story For Green Thumb Industries Inc. (CSE:GTII)
Mar 03Green Thumb Industries (CSE:GTII) Has A Pretty Healthy Balance Sheet
Dec 24These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Sep 18Here's Why Green Thumb Industries Inc.'s (CSE:GTII) CEO May Deserve A Raise
Jun 21We Think That There Are Issues Underlying Green Thumb Industries' (CSE:GTII) Earnings
Mar 25Results: Green Thumb Industries Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Calculating The Intrinsic Value Of Green Thumb Industries Inc. (CSE:GTII)
Mar 08Here's Why Green Thumb Industries (CSE:GTII) Has A Meaningful Debt Burden
Feb 10
Investors Who Bought Green Thumb Industries (CSE:GTII) Shares A Year Ago Are Now Up 176%
Jan 06Green Thumb Industries Inc.'s (CSE:GTII) Has Found A Path To Profitability
Dec 11Rentabilidad de los accionistas
| GTII | CA Pharmaceuticals | Mercado CA | |
|---|---|---|---|
| 7D | -21.3% | -18.5% | 2.5% |
| 1Y | 51.5% | 45.0% | 7.6% |
Rentabilidad vs. Industria: GTII superó a la industria Canadian Pharmaceuticals, que obtuvo un rendimiento del 44.3% el año pasado.
Rentabilidad vs. Mercado: GTII superó al mercado Canadian, que obtuvo un rendimiento del 5.5% el año pasado.
Volatilidad de los precios
| GTII volatility | |
|---|---|
| GTII Average Weekly Movement | 12.7% |
| Pharmaceuticals Industry Average Movement | 14.8% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 3.1% |
Precio estable de las acciones: El precio de las acciones de GTII ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GTII (9%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2014 | 4,561 | Ben Kovler | www.gtigrows.com |
Green Thumb Industries Inc. fabrica, distribuye, comercializa y vende productos de cannabis para uso médico y para adultos en Estados Unidos. Opera a través de dos segmentos: venta al por menor y bienes de consumo envasados. La empresa ofrece flores de cannabis; productos procesados y envasados, incluidos pre-rolls, concentrados, vapes, cápsulas, tinturas, comestibles, tópicos y otros productos relacionados con el cannabis bajo las marcas &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles y RHYTHM.
Resumen de fundamentos de Green Thumb Industries Inc.
| Estadísticas fundamentales de GTII | |
|---|---|
| Capitalización bursátil | CA$3.95b |
| Beneficios(TTM) | CA$49.78m |
| Ingresos (TTM) | CA$1.45b |
79.3x
Ratio precio-beneficio (PE)2.7x
Ratio precio-ventas (PS)¿Está GTII sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de GTII | |
|---|---|
| Ingresos | US$1.05b |
| Coste de los ingresos | US$528.06m |
| Beneficio bruto | US$526.50m |
| Otros gastos | US$490.23m |
| Beneficios | US$36.27m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 08, 2024
| Beneficios por acción (BPA) | 0.15 |
| Margen bruto | 49.93% |
| Margen de beneficio neto | 3.44% |
| Ratio deuda/patrimonio | 18.1% |
¿Cómo se ha desempeñado GTII a largo plazo?
Ver rendimiento histórico y comparativa